ProMIS Share Price

ProMIS Share Price

NASDAQ: PMN | Micro Cap | Healthcare
$3.12
-$0.20 (-6.17%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

ProMIS Stock Performance

Open
$3.28
Prev. Close
$3.32
Circuit Range
N/A
Day Range
$3.11 - $3.29
Year Range
$0.29 - $27.05
Volume
924
Average Traded
$3.23

ProMIS Share Price Today

As of 19 November 2026, ProMIS Neurosciences Inc. (ON)'s share price is $3.12. The stock opened at $3.28, compared to its previous close of $3.32. During today's trading session, ProMIS Neurosciences Inc. (ON)'s share price traded between $3.11 and $3.29, with an average price of $3.20. Over the past 52 weeks, the stock has recorded a high of $27.05 and a low of $0.29. In terms of performance, ProMIS Neurosciences Inc. (ON)'s share price has declined by 72.01% over the last six months and is down 53.82% on a year-on-year basis.

ProMIS Share Price Chart

Line chart of the ProMIS price trend over the selected period. The price fell overall, ranging from 3.11 to 3.29, ending at 3.12.
$3.11$3.29
L
Show Current Price
H

ProMIS Stock Fundamentals & Key Indicators

Market Cap
$5.47M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.33
Revenue (TTM)
$0.00
Return On Equity (TTM)
-92.93%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
23.52%

ProMIS Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$10.67-$8.24-$11.73-$8.16
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A22.77%-42.35%30.43%

ProMIS Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$18.06-$13.21$2.78-$39.72
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A26.85%121.04%-1528.78%

ProMIS Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.00.00.00.02
Current Assets9.1818.9113.626.9
Total Assets9.1818.9113.626.92
Non Current Liabilities0.030.20.091.86
Current Liabilities10.412.229.356.41
Total Liabilities10.442.429.448.27
Shareholders' Equity-1.2616.494.18-1.35

ProMIS Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-28.12-27.18-10.84-17.03
Investing0.00.00.00.0
Financing20.9427.8817.756.49

Corporate Actions

Split
Ex-date: 28 Nov 2025

About ProMIS

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Compnies product candidates are PMN310, PMN267, and PMN442. Lead product candidate is PMN310, a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 is companies second lead product candidate targeting ALS.

ProMIS Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.30
$3.11
-8.80%
Oct 2026
$10.51
$3.41
-67.27%
Sep 2026
$13.38
$10.42
-25.89%
Aug 2026
$14.27
$14.06
+2.03%
Jul 2026
$13.47
$13.78
+2.91%
Jun 2026
$10.48
$13.39
+20.31%
May 2026
$11.01
$11.13
+1.09%
Apr 2026
$12.96
$11.01
-14.72%
Mar 2026
$21.21
$12.91
-45.18%
Feb 2026
$13.41
$23.55
+66.43%
Jan 2026
$7.04
$14.15
+102.43%
Dec 2025
$6.75
$6.99
+3.63%

ProMIS Share Price FAQs